Multiparametric Flow Cytometry for Identification and Fluorescence Activated Cell Sorting of Five Distinct B-Cell Subpopulations in Normal Tonsil Tissue

Malene Krag Kjeldsen(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Mette Nyegaard(Statens Serum Institut), Alexander Schmitz(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Preben Johansen(Chr. Hansen (Denmark)), Alberto Órfão(Universidad de Salamanca), Michael Gaihede(Chr. Hansen (Denmark)), Anne Bukh(Aalborg University Hospital), Martin Boegsted(Aalborg University Hospital), Martín Pérez‐Andrés(Universidad de Salamanca)

American Journal of Clinical Pathology

November 17, 2011

10.1309/ajcpdqnp2u5dzhvv

Cited by 39

Related Papers

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

|Blood|2022|2.8k

Common variants conferring risk of schizophrenia

|Nature|2009|1.7k

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

|Blood|2008|479

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396